vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $12.1M, roughly 1.7× TRANSCONTINENTAL REALTY INVESTORS INC). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -541.1%, a 609.9% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 2.3%). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 0.7%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.
AGIO vs TCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $12.1M |
| Net Profit | $-108.0M | $8.3M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | -28.9% |
| Net Margin | -541.1% | 68.8% |
| Revenue YoY | 86.1% | 2.3% |
| Net Profit YoY | -11.9% | 7577.8% |
| EPS (diluted) | $-1.86 | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $12.1M | ||
| Q3 25 | $12.9M | $12.8M | ||
| Q2 25 | $12.5M | $12.2M | ||
| Q1 25 | $8.7M | $12.0M | ||
| Q4 24 | $10.7M | $11.8M | ||
| Q3 24 | $9.0M | $11.6M | ||
| Q2 24 | $8.6M | $11.8M | ||
| Q1 24 | $8.2M | $11.9M |
| Q4 25 | $-108.0M | $8.3M | ||
| Q3 25 | $-103.4M | $724.0K | ||
| Q2 25 | $-112.0M | $169.0K | ||
| Q1 25 | $-89.3M | $4.6M | ||
| Q4 24 | $-96.5M | $108.0K | ||
| Q3 24 | $947.9M | $1.7M | ||
| Q2 24 | $-96.1M | $1.5M | ||
| Q1 24 | $-81.5M | $2.5M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | -28.9% | ||
| Q3 25 | -907.4% | -10.9% | ||
| Q2 25 | -1020.1% | -6.8% | ||
| Q1 25 | -1222.0% | -5.3% | ||
| Q4 24 | -1165.3% | -14.3% | ||
| Q3 24 | -1146.9% | -14.4% | ||
| Q2 24 | -1228.3% | -9.2% | ||
| Q1 24 | -1124.3% | -11.2% |
| Q4 25 | -541.1% | 68.8% | ||
| Q3 25 | -803.1% | 5.6% | ||
| Q2 25 | -899.4% | 1.4% | ||
| Q1 25 | -1023.3% | 38.5% | ||
| Q4 24 | -899.6% | 0.9% | ||
| Q3 24 | 10574.7% | 14.7% | ||
| Q2 24 | -1115.7% | 12.7% | ||
| Q1 24 | -995.8% | 21.4% |
| Q4 25 | $-1.86 | $0.97 | ||
| Q3 25 | $-1.78 | $0.08 | ||
| Q2 25 | $-1.93 | $0.02 | ||
| Q1 25 | $-1.55 | $0.53 | ||
| Q4 24 | $-1.44 | $0.01 | ||
| Q3 24 | $16.22 | $0.20 | ||
| Q2 24 | $-1.69 | $0.17 | ||
| Q1 24 | $-1.45 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $89.0M |
| Total DebtLower is stronger | — | $210.8M |
| Stockholders' EquityBook value | $1.2B | $846.7M |
| Total Assets | $1.3B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $89.0M | ||
| Q3 25 | $92.7M | $82.7M | ||
| Q2 25 | $80.9M | $73.5M | ||
| Q1 25 | $79.0M | $88.6M | ||
| Q4 24 | $76.2M | $99.7M | ||
| Q3 24 | $253.7M | $131.6M | ||
| Q2 24 | $84.5M | $127.5M | ||
| Q1 24 | $118.8M | $130.8M |
| Q4 25 | — | $210.8M | ||
| Q3 25 | — | $223.5M | ||
| Q2 25 | — | $212.4M | ||
| Q1 25 | — | $198.2M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | — | $180.3M | ||
| Q2 24 | — | $177.4M | ||
| Q1 24 | — | $178.3M |
| Q4 25 | $1.2B | $846.7M | ||
| Q3 25 | $1.3B | $838.4M | ||
| Q2 25 | $1.4B | $837.7M | ||
| Q1 25 | $1.5B | $837.3M | ||
| Q4 24 | $1.5B | $832.3M | ||
| Q3 24 | $1.6B | $832.2M | ||
| Q2 24 | $660.5M | $830.4M | ||
| Q1 24 | $743.9M | $828.9M |
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $773.1M | $1.0B | ||
| Q1 24 | $849.7M | $1.0B |
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-2.9M |
| Free Cash FlowOCF − Capex | $-97.3M | — |
| FCF MarginFCF / Revenue | -487.5% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | -0.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-2.9M | ||
| Q3 25 | $-88.2M | $8.2M | ||
| Q2 25 | $-77.1M | $-2.9M | ||
| Q1 25 | $-111.5M | $-7.4M | ||
| Q4 24 | $-133.2M | $1.3M | ||
| Q3 24 | $-84.2M | $13.7M | ||
| Q2 24 | $-72.6M | $-511.0K | ||
| Q1 24 | $-99.9M | $3.9M |
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | — | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | — | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | -0.35× | ||
| Q3 25 | — | 11.28× | ||
| Q2 25 | — | -17.24× | ||
| Q1 25 | — | -1.61× | ||
| Q4 24 | — | 12.13× | ||
| Q3 24 | -0.09× | 8.03× | ||
| Q2 24 | — | -0.34× | ||
| Q1 24 | — | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
